Yves E. Henrotin
Bone and Cartilage Research Unit
Institute of pathology
CHU Sart-Tilman
4000 Liège
Belgium
Name/email consistency: high
- Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Lambert, C., Mathy-Hartert, M., Dubuc, J.E., Montell, E., Vergés, J., Munaut, C., Noël, A., Henrotin, Y. Arthritis Res. Ther. (2012)
- Intra-articular use of a medical device composed of hyaluronic acid and chondroitin sulfate (Structovial CS): effects on clinical, ultrasonographic and biological parameters. Henrotin, Y., Hauzeur, J.P., Bruel, P., Appelboom, T. BMC. Res. Notes (2012)
- Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Henrotin, Y., Mobasheri, A., Marty, M. Arthritis Res. Ther. (2012)
- Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Henrotin, Y., Gharbi, M., Mazzucchelli, G., Dubuc, J.E., De Pauw, E., Deberg, M. Arthritis Rheum. (2012)
- Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Henrotin, Y., Lambert, C., Couchourel, D., Ripoll, C., Chiotelli, E. Osteoarthr. Cartil. (2011)
- Study of the information delivery by general practitioners and rheumatologists to patients with acute low back pain. Henrotin, Y., Moyse, D., Bazin, T., Cedraschi, C., Duplan, B., Duquesnoy, B., Laroche, F., Valat, J.P., Marty, M. Eur. Spine. J (2011)
- Biological actions of curcumin on articular chondrocytes. Henrotin, Y., Clutterbuck, A.L., Allaway, D., Lodwig, E.M., Harris, P., Mathy-Hartert, M., Shakibaei, M., Mobasheri, A. Osteoarthr. Cartil. (2010)
- Biochemical biomarkers of oxidative collagen damage. Henrotin, Y., Deberg, M., Mathy-Hartert, M., Deby-Dupont, G. Adv. Clin. Chem (2009)
- Subchondral bone in osteoarthritis physiopathology: state-of-the art and perspectives. Henrotin, Y., Pesesse, L., Sanchez, C. Biomed. Mater. Eng (2009)
- Antioxidant to treat osteoarthritis: dream or reality?. Henrotin, Y., Kurz, B. Curr. Drug. Targets (2007)
- Type II collagen markers in osteoarthritis: what do they indicate?. Henrotin, Y., Addison, S., Kraus, V., Deberg, M. Curr. Opin. Rheumatol (2007)
- Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. Henrotin, Y.E., Deberg, M.A., Crielaard, J.M., Piccardi, N., Msika, P., Sanchez, C. J. Rheumatol. (2006)
- Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Henrotin, Y., Kurz, B., Aigner, T. Osteoarthr. Cartil. (2005)
- Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. Henrotin, Y., Sanchez, C., Balligand, M. Vet. J. (2005)
- Type II collagen peptides for measuring cartilage degradation. Henrotin, Y., Deberg, M., Dubuc, J.E., Quettier, E., Christgau, S., Reginster, J.Y. Biorheology (2004)
- Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. Henrotin, Y.E., Sanchez, C., Deberg, M.A., Piccardi, N., Guillou, G.B., Msika, P., Reginster, J.Y. J. Rheumatol. (2003)
- The role of reactive oxygen species in homeostasis and degradation of cartilage. Henrotin, Y.E., Bruckner, P., Pujol, J.P. Osteoarthr. Cartil. (2003)
- In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. Henrotin, Y., de Leval, X., Mathy-Hartet, M., Mouithys-Mickalad, A., Deby-Dupont, G., Dogné, J.M., Delarge, J., Reginster, J.Y. Inflamm. Res. (2001)
